Prognostic performance of serum YKL-40 for one-year clinical outcomes in acute ischemic stroke

por Shi, Guomei, Li, Minghao, E, Yan, Wang, Meng, Gong, Pengyu, Wang, Xiaorong, Lu, Jingye, Wu, Weixiang, Xue, Shouru, Zhou, Junshan, Zhou, Rujuan
Publicado 2023

Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke

por Shi, Guomei, Ke, Dongdong, Gong, Pengyu, Yu, Peng, Zhou, Junshan, Wang, Meng, Zhang, Xiaohao, Wang, Xiaorong, Guo, Minwang, Xu, Mingyang, Zhou, Rujuan
Publicado 2023

The Association between High Mobility Group Box 1 and Stroke-Associated Pneumonia in Acute Ischemic Stroke Patients

por E, Yan, Deng, Qiwen, Shi, Guomei, Li, Zhongyuan, Liu, Chengfang, Wang, Siyu, Lian, Huiwen, Cao, Haiming, Zhang, Xiaohao, Zhang, Yingdong, Gong, Pengyu, Jiang, Teng
Publicado 2022

The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke

por Shi, Guomei, Chen, Wenxiu, Gong, Pengyu, Wang, Meng, Zhou, Junshan, Wang, Xiaorong, Guo, Minwang, Lu, Jingye, Li, Yan, Feng, Hongxuan, Fu, Xuetao, Zhou, Rujuan, Xue, Shouru
Publicado 2021